methotrexate has been researched along with Urinary Tract Infections in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gowarty, JL; Herrington, JD; Patel, IJ | 1 |
| Combe, B; Keystone, E; Landewé, R; Mease, P; Shaughnessy, L; Strand, V; van der Heijde, D; van Vollenhoven, R; VanLunen, B | 1 |
| Cantatore, FP; Corrado, A; D'Onofrio, F; Maruotti, N; Neve, A; Santoro, N | 1 |
| Camp, HS; Emery, P; Friedman, A; Jungerwirth, S; Keystone, EC; Khan, N; Kremer, JM; Othman, AA; Pangan, AL; Wang, L | 1 |
| Brophy, MT; Chang, BH; Hannagan, K; O'Dell, JR; Quach, LT; Soe Thwin, S | 1 |
| Bieroza, I; Krzemień, G; Roszkowska-Blaim, M; Szmigielska, A | 1 |
| Di Rosa, R; Laganà, B; Luzi, G; Salemi, S | 1 |
| de Dios Luna, J; Hidalgo-Tenorio, C; Jiménez-Alonso, J; Martínez-Brocal, A; Sabio, JM; Tallada, M | 1 |
| Aringer, M; Graninger, WB; Smolen, JS; Steiner, G | 1 |
| Beasley, TM; Bridges, SL; Criswell, LA; Edberg, JC; Hughes, LB; Kimberly, RP; Moreland, LW; Seldin, MF | 1 |
| Bijlsma, JW; Kruize, AA; van der Heide, A; van der Veen, MJ | 1 |
| Groenendal, H; Rampen, FH | 1 |
| Allen, LS; Groff, G | 1 |
5 trial(s) available for methotrexate and Urinary Tract Infections
| Article | Year |
|---|---|
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension.
Topics: Adult; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Certolizumab Pegol; Cohort Studies; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Longitudinal Studies; Male; Methotrexate; Middle Aged; Pharyngitis; Polyethylene Glycols; Respiratory Tract Infections; Treatment Outcome; Urinary Tract Infections | 2014 |
A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase 1; Male; Methotrexate; Middle Aged; Nausea; Protein Kinase Inhibitors; Respiratory Tract Infections; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor-alpha; Urinary Tract Infections | 2016 |
Rheumatoid arthritis triple therapy compared with etanercept: difference in infectious and gastrointestinal adverse events.
Topics: Abscess; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Female; Gastritis; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Ileus; Incidence; Infections; Intestinal Obstruction; Linear Models; Male; Methotrexate; Middle Aged; Pancreatitis; Pneumonia; Respiratory Tract Infections; Sulfasalazine; Urinary Tract Infections | 2017 |
Are glucocorticoids a consistent risk factor for infections in rheumatoid arthritis patients under treatment with methotrexate and etanercept?
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Bacterial Infections; Candidiasis, Vulvovaginal; Disease Susceptibility; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Otitis Media; Receptors, Tumor Necrosis Factor; Respiratory Tract Infections; Urinary Tract Infections | 2009 |
Genetic risk factors for infection in patients with early rheumatoid arthritis.
Topics: Age Factors; Aged; Arthritis, Rheumatoid; Etanercept; Female; Genetic Predisposition to Disease; Genotype; Humans; Immunoglobulin G; Lymphotoxin-alpha; Male; Methotrexate; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Receptors, IgG; Receptors, Tumor Necrosis Factor; Risk Factors; Tumor Necrosis Factor-alpha; Urinary Tract Infections | 2004 |
8 other study(ies) available for methotrexate and Urinary Tract Infections
| Article | Year |
|---|---|
Altered methotrexate clearance in the treatment of CNS lymphoma with concurrent use of nitrofurantoin for a urinary tract infection.
Topics: Aged; Central Nervous System Neoplasms; Drug Interactions; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Nitrofurantoin; Urinary Tract Infections | 2019 |
Anti-TNF-α and risk of infections: the experience in one center.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Certolizumab Pegol; Chronic Disease; Comorbidity; Etanercept; Female; Herpes Zoster; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Infections; Infliximab; Male; Medical Records; Methotrexate; Middle Aged; Odds Ratio; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Risk Factors; Tumor Necrosis Factor-alpha; Urinary Tract Infections | 2014 |
[Complex etiology of acute renal failure in a newborn].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Asphyxia Neonatorum; Female; Fetal Diseases; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kidney Tubular Necrosis, Acute; Male; Methotrexate; Nephritis, Interstitial; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Urinary Tract Infections | 2008 |
Urinary tract infections and lupus erythematosus.
Topics: Adult; Age Factors; Antibodies, Antinuclear; Antirheumatic Agents; Escherichia coli; Female; Hospitalization; Humans; Leukopenia; Lupus Erythematosus, Systemic; Male; Methotrexate; Prevalence; Prospective Studies; Recurrence; Risk Factors; Thrombocytopenia; Urinary Tract Infections | 2004 |
Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis; Autoantibodies; Azathioprine; Bacteremia; Cardiolipins; Complement System Proteins; DNA; Escherichia coli Infections; Female; Humans; Immunosuppressive Agents; Infliximab; Lupus Erythematosus, Systemic; Lupus Nephritis; Methotrexate; Middle Aged; Safety; Treatment Outcome; Tumor Necrosis Factor-alpha; Urinary Tract Infections | 2004 |
Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Rheumatoid; Female; Humans; Infections; Male; Methotrexate; Middle Aged; Prospective Studies; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Skin Diseases, Infectious; Urinary Tract Infections | 1994 |
Methotrexate and trimethoprim-sulphamethoxazole--a potentially hazardous combination.
Topics: Aged; Arthritis, Rheumatoid; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leg Ulcer; Methotrexate; Pancytopenia; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1990 |
Treatment of Felty's syndrome with low-dose oral methotrexate.
Topics: Administration, Oral; Aged; Candidiasis; Esophagitis; Felty Syndrome; Female; Humans; Methotrexate; Sinusitis; Staphylococcal Infections; Urinary Tract Infections | 1986 |